BioLineRx BLRX
NASDAQ BLRX
$2.36 -0.07 (-2.88%)
As of: Sep 29, 2026 · 3:07 PM EDT

BioLineRx (BLRX) Current Taxes (2016 - 2018)

Updated

BioLineRx (BLRX) reported Current Taxes of $895,000 for the quarter ended Dec 31, 2018, up 862.4% from $93,000 a year earlier.

Analysis

BioLineRx (BLRX) Current Taxes (2016 - 2018) Analysis & Trends

  • By year, Current Taxes came in at $93,000 in the year ended Dec 31, 2017 (unchanged) and $93,000 in the year ended Dec 31, 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 1.05 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 4.22 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 2.31 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -1.47 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 653.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 BioLineRx 6.34 Bn 6.35 Bn 235,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 895,000.00
Dec 31, 2017 93,000.00
Dec 31, 2016 93,000.00
API Access

BioLineRx Current Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-taxes&ticker=BLRX&period=max&api_key=YOUR_API_KEY